Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
about
Expression of hsa-MIR-204, RUNX2, PPARγ, and BCL2 in Bone Marrow Derived Mesenchymal Stem Cells from Multiple Myeloma Patients and Normal Individuals.Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.Donor T-cell responses and disease progression patterns of multiple myelomaAn Overview of Light Chain Multiple Myeloma: Clinical Characteristics and Rarities, Management Strategies, and Disease Monitoring
P2860
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@ast
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@en
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@nl
type
label
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@ast
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@en
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@nl
prefLabel
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@ast
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@en
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@nl
P356
P1476
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
@en
P2093
S Vincent Rajkumar
P304
P356
10.14694/EDBK_159009
P577
2016-01-01T00:00:00Z